Clinical trial
Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood Biomarkers
NCT05603819 is registered in ClinicalTrials.gov with Alcediag as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood Biomarkers
- Lead sponsor
- Alcediag
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 29, 2022
- Completion date
- September 30, 2024
- Enrollment
- 418 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.